8751 - 8775 of 8808 Results
Title
Year
-
OPENTitle: Longitudinal Assessment of Parkinson’s Motor Symptoms and Dopaminergic Dysfunction Patterns Using DaTSCANJournal Name: Clinical Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 12Issue #:Start Page: 100331End Page: 100331Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1016/j.prdoa.2025.100331Best OA location URL: https://doi.org/10.1016/j.prdoa.2025.100331Citation Count: 1
-
OPENTitle: Sex differences in the clinical manifestation of autosomal dominant frontotemporal dementiaJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 21Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/alz.14630Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alz.14630Citation Count: 5
-
OPENTitle: Aseptic, semi-sealed cranial chamber implants for chronic multi-channel neurochemical and electrophysiological neural recording in nonhuman primatesJournal Name: Journal of Neuroscience MethodsPublisher: Elsevier BVVol: 420Issue #:Start Page: 110467End Page: 110467Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.jneumeth.2025.110467Best OA location URL: https://doi.org/10.1016/j.jneumeth.2025.110467Citation Count: 0
-
OPENTitle: Degeneration of human photosensitive retinal ganglion cells may explain sleep and circadian rhythms disorders in Parkinson’s diseaseJournal Name: Acta Neuropathologica CommunicationsPublisher: Springer Science and Business Media LLCVol: 6Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40478-018-0596-zBest OA location URL: https://actaneurocomms.biomedcentral.com/track/pdf/10.1186/s40478-018-0596-zCitation Count: 72
-
OPENTitle: 0908 Multi-modal Recruitment of Individuals with REM Sleep Behavior Disorder into a Longitudinal Prodromal Parkinson’s StudyJournal Name: SLEEPPublisher: Oxford University Press (OUP)Vol: 46Issue #: Supplement_1Start Page: A400End Page: A400Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/sleep/zsad077.0908Best OA location URL: https://academic.oup.com/sleep/article-pdf/46/Supplement_1/A400/50468111/zsad077.0908.pdfCitation Count: 0
-
OPENTitle: LUBAC assembles a ubiquitin signaling platform at mitochondria for signal amplification and transport of NF‐κB to the nucleusJournal Name: The EMBO JournalPublisher: Springer Science and Business Media LLCVol: 41Issue #: 24Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.15252/embj.2022112006Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.15252/embj.2022112006Citation Count: 26
- Subcortical microstructural diffusion changes correlate with gait impairment in Parkinson's disease2021RESTRICTEDTitle: Subcortical microstructural diffusion changes correlate with gait impairment in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 87Issue #:Start Page: 111End Page: 118Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.05.005Citation Count: 14
- The Parkinson’s phenome—traits associated with Parkinson’s disease in a broadly phenotyped cohort2019OPENTitle: The Parkinson’s phenome—traits associated with Parkinson’s disease in a broadly phenotyped cohortJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 5Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-019-0077-5Best OA location URL: https://doi.org/10.1038/s41531-019-0077-5Citation Count: 40
-
OPENTitle: Population fraction of Parkinson’s disease attributable to preventable risk factorsJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41531-023-00603-zBest OA location URL: https://www.nature.com/articles/s41531-023-00603-z.pdfCitation Count: 10
-
OPENTitle: Design, synthesis, and in vitro evaluation of quinolinyl analogues for α-synuclein aggregationJournal Name: Bioorganic & Medicinal Chemistry LettersPublisher: Elsevier BVVol: 28Issue #: 6Start Page: 1011End Page: 1019Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.bmcl.2018.02.031Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5870887Citation Count: 17
-
OPENTitle: Michael J. Fox Foundation LRRK2 Consortium: geographical differences in returning genetic research data to study participantsJournal Name: Genetics in MedicinePublisher: Elsevier BVVol: 16Issue #: 8Start Page: 644End Page: 645Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1038/gim.2014.55Best OA location URL: http://doi.org/10.1038/gim.2014.55Citation Count: 7
-
RESTRICTEDTitle: A novel brain penetrant c-Abl tyrosine kinase inhibitor: Paving a path forward to success in disease modification in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 108Issue #:Start Page: 105325End Page: 105325Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2023.105325Citation Count: 0
-
OPENTitle: Rab29 activation of the Parkinson's disease‐associated LRRK2 kinaseJournal Name: The EMBO JournalPublisher: Springer Science and Business Media LLCVol: 37Issue #: 1Start Page: 1End Page: 18Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.15252/embj.201798099Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.15252/embj.201798099Citation Count: 351
-
OPENTitle: Olfactory impairment predicts cognitive decline in early Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 25Issue #:Start Page: 45End Page: 51Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2016.02.013Best OA location URL: http://doi.org/10.1016/j.parkreldis.2016.02.013Citation Count: 111
-
OPENTitle: A Novel α‐Synuclein K58N Missense Variant in a Patient with Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.70030Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.70030Citation Count: 0
-
OPENTitle: Measuring Structural Racism: A Guide for Epidemiologists and Other Health ResearchersJournal Name: American Journal of EpidemiologyPublisher: Oxford University Press (OUP)Vol: 191Issue #: 4Start Page: 539End Page: 547Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/aje/kwab239Best OA location URL: https://academic.oup.com/aje/article-pdf/191/4/539/43609257/kwab239.pdfCitation Count: 299
-
OPENTitle: miRSwitch: detecting microRNA arm shift and switch eventsJournal Name: Nucleic Acids ResearchPublisher: Oxford University Press (OUP)Vol: 48Issue #: W1Start Page: W268End Page: W274Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1093/nar/gkaa323Best OA location URL: https://academic.oup.com/nar/article-pdf/48/W1/W268/33432877/gkaa323.pdfCitation Count: 27
-
OPENTitle: FDG PET Parkinson’s disease-related pattern as a biomarker for clinical trials in early stage diseaseJournal Name: NeuroImage: ClinicalPublisher: Elsevier BVVol: 20Issue #:Start Page: 572End Page: 579Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nicl.2018.08.006Best OA location URL: https://doi.org/10.1016/j.nicl.2018.08.006Citation Count: 83
-
OPENTitle: Association study of DNAJC13, UCHL1, HTRA2, GIGYF2, and EIF4G1 with Parkinson's diseaseJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 100Issue #:Start Page: 119.e7End Page: 119.e13Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2020.10.019Best OA location URL: https://hal.umontpellier.fr/hal-03226126Citation Count: 30
-
OPENTitle: Single molecule array measures of LRRK2 kinase activity in serum link Parkinson’s disease severity to peripheral inflammationJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 19Issue #: 1Start Page: 47End Page: 47Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-024-00738-4Best OA location URL: https://molecularneurodegeneration.biomedcentral.com/counter/pdf/10.1186/s13024-024-00738-4Citation Count: 8
-
OPENTitle: Association between insomnia disorder and cognitive function in middle-aged and older adults: a cross-sectional analysis of the Canadian Longitudinal Study on AgingJournal Name: SleepPublisher: Oxford University Press (OUP)Vol: 42Issue #: 8Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/sleep/zsz114Best OA location URL: https://academic.oup.com/sleep/article-pdf/42/8/zsz114/29106505/zsz114.pdfCitation Count: 62
-
OPENTitle: Elevation of gangliosides in four brain regions from Parkinson’s disease patients with a GBA mutationJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00363-2Best OA location URL: https://www.nature.com/articles/s41531-022-00363-2.pdfCitation Count: 16
-
OPENTitle: Two C-terminal sequence variations determine differential neurotoxicity between human and mouse α-synucleinJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-020-00380-wBest OA location URL: https://molecularneurodegeneration.biomedcentral.com/track/pdf/10.1186/s13024-020-00380-wCitation Count: 13
- Identifying Protective Drugs for Parkinson's Disease in Health‐Care Databases Using Machine Learning2022OPENTitle: Identifying Protective Drugs for Parkinson's Disease in Health‐Care Databases Using Machine LearningJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 12Start Page: 2376End Page: 2385Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/mds.29205Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29205Citation Count: 10
-
OPENTitle: Pimavanserin versus quetiapine for the treatment of psychosis in Parkinson's disease and dementia with Lewy bodiesJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 69Issue #:Start Page: 119End Page: 124Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.11.009Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7061324Citation Count: 39